Scarica l'app Stockscreener
3.25
16.91%
0.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CAMP Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.78
Aprire:
$3.2
Volume 24 ore:
1.29M
Relative Volume:
1.73
Capitalizzazione di mercato:
$65.52M
Reddito:
$264.74M
Utile/perdita netta:
$-49.71M
Rapporto P/E:
-0.7935
EPS:
-4.0959
Flusso di cassa netto:
$-43.55M
1 W Prestazione:
+113.82%
1M Prestazione:
+135.51%
6M Prestazione:
-38.45%
1 anno Prestazione:
+712.50%
Intervallo 1D:
$3.10
$3.48
Intervallo di 1 settimana:
$1.46
$3.70
Portata 52W:
$1.305
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
Nome
Camp 4 Therapeutics Corp
Settore
Industria
Telefono
617-651-8867
Indirizzo
ONE KENDALL SQUARE, CAMBRIDGE, CA
Confronta CAMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
3.25 | 56.25M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Iniziato | Wedbush | Outperform |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | Piper Sandler | Overweight |
| 2024-11-05 | Iniziato | William Blair | Outperform |
| 2022-08-16 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2021-12-22 | Downgrade | Craig Hallum | Buy → Hold |
| 2021-09-24 | Reiterato | Craig Hallum | Buy |
| 2021-06-25 | Reiterato | Craig Hallum | Buy |
| 2020-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-04-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-05 | Reiterato | Craig Hallum | Buy |
| 2019-12-20 | Reiterato | Craig Hallum | Buy |
| 2019-12-20 | Downgrade | First Analysis Sec | Outperform → Neutral |
| 2019-06-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2019-05-29 | Downgrade | Goldman | Neutral → Sell |
| 2019-05-01 | Reiterato | Craig Hallum | Buy |
| 2019-03-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-01-25 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-12-21 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2018-12-14 | Reiterato | B. Riley FBR | Buy |
| 2018-12-11 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2018-12-11 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2018-11-27 | Iniziato | Goldman | Neutral |
| 2018-10-15 | Iniziato | Jefferies | Hold |
| 2018-09-28 | Reiterato | Craig Hallum | Hold |
| 2018-04-27 | Reiterato | Craig Hallum | Hold |
| 2018-03-08 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-02-16 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
Mostra tutto
Camp 4 Therapeutics Corp Borsa (CAMP) Ultime notizie
Analyzing Camp4 Therapeutics Corporation with multi timeframe chartsMarket Performance Summary & Reliable Volume Spike Trade Alerts - newser.com
What’s next for Camp4 Therapeutics Corporation stock priceEarnings Performance Report & Verified Short-Term Plans - newser.com
How institutional ownership impacts Camp4 Therapeutics Corporation stockGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Using AI based signals to follow Camp4 Therapeutics CorporationJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Can volume confirm reversal in Camp4 Therapeutics Corporation2025 Technical Overview & Stock Timing and Entry Methods - newser.com
How to use a screener to detect Camp4 Therapeutics Corporation breakoutsMarket Movers & High Accuracy Buy Signal Tips - newser.com
Camp4 Therapeutics Corporation stock retracement – recovery analysisEarnings Miss & Breakout Confirmation Alerts - Newser
Visualizing Camp4 Therapeutics Corporation stock with heatmapsWeekly Market Outlook & Precise Swing Trade Alerts - Newser
Real time scanner hits for Camp4 Therapeutics Corporation explainedGlobal Markets & Risk Managed Investment Signals - Newser
Will Camp4 Therapeutics Corporation rebound enough to break even2025 Short Interest & Verified Technical Signals - Newser
How hedge fund analytics apply to Camp4 Therapeutics Corporation stockMarket Growth Report & Stepwise Trade Signal Implementation - Newser
Multi asset correlation models including Camp4 Therapeutics CorporationJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - Newser
Market reaction to Camp4 Therapeutics Corporation’s recent newsGap Up & Daily Oversold Bounce Ideas - Newser
How to build a dashboard for Camp4 Therapeutics Corporation stockJuly 2025 Breakouts & Smart Money Movement Tracker - Newser
Analyzing drawdowns of Camp4 Therapeutics Corporation with statistical toolsQuarterly Investment Review & Reliable Volume Spike Alerts - Newser
What momentum shifts mean for Camp4 Therapeutics Corporation2025 Price Momentum & AI Based Trade Execution Alerts - Newser
Candlestick signals on Camp4 Therapeutics Corporation stock today2025 Technical Overview & Low Drawdown Trading Strategies - Newser
Major Investments Pour into CAMP4 Therapeutics Corporation! - TipRanks
Nashat Amir buys Camp4 Therapeutics (CAMP) shares worth $1.99m By Investing.com - Investing.com Nigeria
Nashat Amir buys Camp4 Therapeutics (CAMP) shares worth $1.99m - Investing.com India
CAMP4 Therapeutics Secures $100M in Private Placement - MSN
Technical analysis overview for Camp4 Therapeutics Corporation stock2025 Fundamental Recap & AI Powered Trade Plan Recommendations - Newser
Camp4 Therapeutics Corporation Announces Management Changes - MarketScreener
Camp4 Therapeutics Corporation announced that it expects to receive $50.00716 million in funding from Janus Henderson Investors, Balyasny Asset Management L.P., Vivo Capital, LLC, Adage Capital Management, L.P., Trails Edge Capital Partners, LLC, S - MarketScreener
CAMP4 Therapeutics stock soars after $100 million private placement - Investing.com
CAMP4 Therapeutics stock soars after $100 million private placement By Investing.com - Investing.com UK
CAMP4 Announces an Oversubscribed Private Placement of up - GlobeNewswire
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders - GlobeNewswire Inc.
Visual trend scoring systems applied to Camp4 Therapeutics CorporationJuly 2025 Drop Watch & Long Hold Capital Preservation Tips - Newser
Applying Wyckoff theory to Camp4 Therapeutics Corporation stockTrade Entry Report & Short-Term Trading Opportunity Alerts - Newser
Has Camp4 Therapeutics Corporation formed a bullish divergenceWatch List & Weekly Breakout Stock Alerts - Newser
Long term hold vs stop loss in Camp4 Therapeutics CorporationEarnings Trend Report & Verified Short-Term Trading Plans - Newser
what momentum shifts mean for camp4 therapeutics corporation2025 Top Gainers & High Yield Stock Recommendations - Newser
How sentiment analysis helps forecast Camp4 Therapeutics CorporationJuly 2025 Fed Impact & AI Driven Price Forecasts - Newser
What the charts say about Camp4 Therapeutics Corporation todayRisk Management & Reliable Entry Point Trade Alerts - Newser
Exit strategy if you’re trapped in Camp4 Therapeutics CorporationJuly 2025 Price Swings & Breakout Confirmation Alerts - Newser
Using Python tools to backtest Camp4 Therapeutics Corporation strategiesMarket Rally & Advanced Technical Signal Analysis - Newser
Can a trend reversal in Camp4 Therapeutics Corporation lead to recoveryVolume Spike & AI Driven Stock Reports - Newser
Camp 4 Therapeutics Corp Azioni (CAMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):